ANTISENSE MODULATION OF BCL2-ASSOCIATED X PROTEIN EXPRESSION

Details for Australian Patent Application No. 2002316698 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors ZHANG, Hong; WATT, Andrew, T.

Pub. Number AU-A-2002316698

PCT Number PCT/US02/22417

PCT Pub. Number WO2003/008543

Priority 09/908,147 17.07.01 US

Filing date 13 July 2002

Wipo publication date 3 March 2003

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 09/908,147 17.07.01 US

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002316698

8 April 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002316699-INTEGRATED ADJUSTABLE LUMBAR SUPPORT AND TRIM ATTACHMENT SYSTEM

2002316697-300MM SINGLE STACKABLE FILM FRAME CARRIER